Japan Endovascular Treatment Conference 2015 JET2015 General Presentation.

Slides:

Advertisements

Similar presentations

Japan Endovascular Treatment Conference 2014 JET2014 Digital Poster.

Advertisements

Japan Endovascular Treatment Conference 2014 JET2014 コメディカルセッション.

DISCLOSURE STATEMENT Speaker: INSERT NAME Affiliation / Financial Interest Organization [TYPE] [NAMES OF COMPANIES] PAS Annual Meetings, May 2-5, 2009,

Japan Society for Hematopoietic Cell Transplantation COI disclosure Name of first author ： e.g., John Doe I have no personal or financial interests to.

Speaker Disclosure Explanation

Japan Endovascular Treatment Conference 2016 JET2016 General Presentation.

Disclosure Basics Disclosure must always be done in all CME accredited activities (lectures, workshops, etc). One must disclose even if they have nothing.

Financial Disclosures Financial interests, arrangements or affiliations that could be perceived as a real or apparent “conflict of interest” in the context.

COI Disclosure Information Example 2-1 Lead Presenter: Jane Doe Responsible Researcher: Jane Smith We have no financial relationships to disclose.

Financial Interest Disclosure (over the past 24 months) Commercial Interest Relationship Company A advisory board, consultant, investigator Company B speaker.

Speaker Name: Disclosure of Relevant Financial Relationships

[Sample statement for poster presentations]

We have no conflict of interests related to

for Respiratory Care and Rehabilitation

COI Disclosure of First Author

Faculty Disclosure Off-Label Product Use

A Sample Slide Format to disclose your COI Status

The Japanese Society of Hematology COI Disclosure Name of Authors

DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.

Relevant Financial Disclosure(s)

Part I Who should disclose at my CME event?

Conflict of Interest Disclosure

Conflict of Interest Shilene Johnson- Research Compliance Specialist

Disclosure Information 87th Annual Scientific Meeting Speaker’s Name Here I have the following financial relationships to disclose: (select those that.

Significant (greater than $10K)

Faculty Disclosure Off-Label Product Use

Conflict of Interest Disclosure:

Disclosure Information 89th Annual Scientific Meeting I have the following financial relationships to disclose: (select those that.

Disclosure Information AACPDM 72nd Annual Meeting | October 9-13, 2018

The Japan Diabetes Society

FINANCIAL DISCLOSURES

Disclosure of conflicts of interest – explanation

If yes, give company names.

COI Disclosure All authors Name : （◎ Corresponding author）

Speaker Name: Disclosure of Relevant Financial Relationships

DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.

Conflict of interest disclosure

DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.

COI Disclosure STRUCTURE CLUB JAPAN Name of First Author

DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.

Disclosures The project was funded from the following sources:

Financial Disclosure Financial Interest / Affiliation

Faculty Disclosure Off-Label Product Use

Disclosures Relevant financial relationships in the past twelve months by presenter or spouse/partner. Employment: Company Name(s) Speakers Bureau:

Title of Talk Speaker name.

Use the following slide to disclose any conflicts of interest

DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.

Disclosure Information 90th Annual Scientific Meeting I have the following financial relationships to disclose: (select those that.

Disclosure of conflicts of interest

Speaker Name: Disclosure of Relevant Financial Relationships

We have no conflict of interests related to

COI Disclosure Name of Lead Presenter:○○○○

Disclosure of conflicts of interest

Post of executive /consultant： AB Pharma Co.,

COI Disclosure Japan Diabetes Society

Faculty Disclosure Off-Label Product Use

We have no conflict of interests related to

for Respiratory Care and Rehabilitation

Faculty Disclosure Off-Label Product Use

If yes, give company names.

Conflict of Interest Disclosure , Salary: Royalty: Receipt of Intellectual Property Rights/Patent Holder: Consulting Fees.

COI Disclosure All authors Name : （◎ Corresponding author）

Japanese Society of Nephrology ＣＯＩ disclosure presenter： ○○○○,. ○○○○(

List disclosure information here.

Financial Disclosure Financial Interest / Affiliation

THE TITLE OF MY TALK John Doe, M.D. Professor Department of Neurology

　*Please use this slide template when there is no

Japan Oncoplastic Breast Surgery Society

　Form1-A　There is no state of conflict of interest requiring disclosure

COI Disclosure For speakers with a COI to declare

Presentation transcript:

Japan Endovascular Treatment Conference 2015 JET2015 General Presentation

Japan Endovascular Treatment Conference 2015Japan Endovascular Treatment Conference 20 COI Disclosure; Name, MD. For the 12 months preceding this CME activity, I disclose the following types of financial relationships: Honoraria received from: Consulted for: Held common stock in: Research, clinical trial, or drug study funds received from: I WILL or WILL NOT be discussing products that are investigational or not labeled for use under discussion.

Japan Endovascular Treatment Conference 2015Japan Endovascular Treatment Conference 20

Japan Endovascular Treatment Conference 2015

JET2015 Knowledge Capital Congrès Convention Center February 20(Fri)-22(Sun)2015